U.S. Osteoporosis Therapeutics Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This research service highlights the emerging opportunities in the U.S. osteoporosis therapeutics market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - bisphosphonates, SERMs, calcitonins and parathyroid hormones. Also included are individual revenue and patient forecasts for Fosamax, Actonel, Boniva, Zometa, Evista, lasofoxifene, basedoxifene, Forteo, Preos and Protos.

Table of Contents

U.S. Osteoporosis Therapeutics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Osteoporosis Therapeutics Markets, Total MarketOverviewScope and SegmentationResearch MethodologyIntroductionMarket and Technology TrendsMarket DynamicsDemand AnalysisPatient ForecastsRevenue ForecastsFactors Affecting Market GrowthIndustry Issues and ChallengesCompetitive LandscapeCompetitive StructurePipeline AnalysisMarket Share AnalysisFrost & Sullivan AwardsProduct of the Year AwardIndustry Innovation and Advancement of the Year AwardProduct Innovation AwardTechnology Excellence AwardEntrepreneurial Company of the YearU.S. Osteoporosis Therapeutics Markets, Bisphosphonates MarketOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsPricing TrendsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Osteoporosis Therapeutics Markets, SERMs MarketOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsPricing TrendsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Osteoporosis Therapeutics Markets, Calcitonins MarketOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsPricing TrendsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Osteoporosis Therapeutics Markets, Parathyroid Hormones MarketOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsPricing TrendsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Osteoporosis Therapeutics Markets, AppendixDecision Support DatabasePopulation 65 and OlderFemale PopulationObstetricians and GynecologistsMedicare EnrollmentPrivate Health Insurance




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.